These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 9377947

  • 1. Alpha1-antitrypsin augmentation therapy.
    Pierce JA.
    Chest; 1997 Oct; 112(4):872-4. PubMed ID: 9377947
    [No Abstract] [Full Text] [Related]

  • 2. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR, Burdon JG, Piitulainen E, Sandhaus RA, Seersholm N, Stocks JM, Stoel BC, Huang L, Yao Z, Edelman JM, McElvaney NG, RAPID Trial Study Group.
    Lancet; 2015 Jul 25; 386(9991):360-8. PubMed ID: 26026936
    [Abstract] [Full Text] [Related]

  • 3. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.
    Seersholm N, Wencker M, Banik N, Viskum K, Dirksen A, Kok-Jensen A, Konietzko N.
    Eur Respir J; 1997 Oct 25; 10(10):2260-3. PubMed ID: 9387950
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding.
    Stoller JK, Aboussouan LS.
    Thorax; 2004 Aug 25; 59(8):708-12. PubMed ID: 15282394
    [Abstract] [Full Text] [Related]

  • 7. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
    Wencker M, Banik N, Buhl R, Seidel R, Konietzko N.
    Pneumologie; 1998 Oct 25; 52(10):545-52. PubMed ID: 9847632
    [Abstract] [Full Text] [Related]

  • 8. [Hereditary alpha-1-antitrypsin deficiency can cause COPD. Substitution treatment seems to result in fewer infections and prolonged survival].
    Janciauskiene S.
    Lakartidningen; 1998 Oct 25; 104(48):3631-4, 3637-8. PubMed ID: 18193673
    [No Abstract] [Full Text] [Related]

  • 9. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Heresi GA, Stoller JK.
    Expert Opin Biol Ther; 2008 Apr 25; 8(4):515-26. PubMed ID: 18352854
    [Abstract] [Full Text] [Related]

  • 10. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group.
    Wencker M, Banik N, Buhl R, Seidel R, Konietzko N.
    Eur Respir J; 1998 Feb 25; 11(2):428-33. PubMed ID: 9551749
    [Abstract] [Full Text] [Related]

  • 11. Augmentation therapy for alpha-1 antitrypsin deficiency--not enough evidence to support its use yet!
    McCarthy C, Dimitrov BD.
    COPD; 2010 Jun 25; 7(3):234; author reply 235-6. PubMed ID: 20486824
    [No Abstract] [Full Text] [Related]

  • 12. Case detection of alpha1-antitrypsin deficiency: does it help the patient or the doctor?
    Stolk J.
    Eur Respir J; 2005 Oct 25; 26(4):561-2. PubMed ID: 16204582
    [No Abstract] [Full Text] [Related]

  • 13. Lung disease due to alpha 1-antitrypsin deficiency.
    Wiedemann HP, Stoller JK.
    Curr Opin Pulm Med; 1996 Mar 25; 2(2):155-60. PubMed ID: 9363132
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency.
    Dirksen A, Piitulainen E, Parr DG, Deng C, Wencker M, Shaker SB, Stockley RA.
    Eur Respir J; 2009 Jun 25; 33(6):1345-53. PubMed ID: 19196813
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. α1-Proteinase inhibitor (human) in the treatment of hereditary emphysema secondary to α1-antitrypsin deficiency: number and costs of years of life gained.
    Sclar DA, Evans MA, Robison LM, Skaer TL.
    Clin Drug Investig; 2012 May 01; 32(5):353-60. PubMed ID: 22480280
    [Abstract] [Full Text] [Related]

  • 20. Long-term experience in the treatment of α1-antitrypsin deficiency: 25 years of augmentation therapy.
    Teschler H.
    Eur Respir Rev; 2015 Mar 01; 24(135):46-51. PubMed ID: 25726554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.